BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21118961)

  • 1. Sp100 as a potent tumor suppressor: accelerated senescence and rapid malignant transformation of human fibroblasts through modulation of an embryonic stem cell program.
    Negorev DG; Vladimirova OV; Kossenkov AV; Nikonova EV; Demarest RM; Capobianco AJ; Showe MK; Rauscher FJ; Showe LC; Maul GG
    Cancer Res; 2010 Dec; 70(23):9991-10001. PubMed ID: 21118961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sp100A promotes chromatin decondensation at a cytomegalovirus-promoter-regulated transcription site.
    Newhart A; Negorev DG; Rafalska-Metcalf IU; Yang T; Maul GG; Janicki SM
    Mol Biol Cell; 2013 May; 24(9):1454-68. PubMed ID: 23485562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sp100 isoform-specific regulation of human adenovirus 5 gene expression.
    Berscheminski J; Wimmer P; Brun J; Ip WH; Groitl P; Horlacher T; Jaffray E; Hay RT; Dobner T; Schreiner S
    J Virol; 2014 Jun; 88(11):6076-92. PubMed ID: 24623443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradation.
    Negorev DG; Vladimirova OV; Maul GG
    J Virol; 2009 May; 83(10):5168-80. PubMed ID: 19279115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for separate ND10-binding and homo-oligomerization domains of Sp100.
    Negorev D; Ishov AM; Maul GG
    J Cell Sci; 2001 Jan; 114(Pt 1):59-68. PubMed ID: 11112690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two overlapping regions within the N-terminal half of the herpes simplex virus 1 E3 ubiquitin ligase ICP0 facilitate the degradation and dissociation of PML and dissociation of Sp100 from ND10.
    Perusina Lanfranca M; Mostafa HH; Davido DJ
    J Virol; 2013 Dec; 87(24):13287-96. PubMed ID: 24089549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression.
    Negorev DG; Vladimirova OV; Ivanov A; Rauscher F; Maul GG
    J Virol; 2006 Aug; 80(16):8019-29. PubMed ID: 16873258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral FGARAT Homolog ORF75 of Rhesus Monkey Rhadinovirus Effects Proteasomal Degradation of the ND10 Components SP100 and PML.
    Hahn AS; Großkopf AK; Jungnickl D; Scholz B; Ensser A
    J Virol; 2016 Sep; 90(17):8013-28. PubMed ID: 27356898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SP100 component of ND10 enhances accumulation of PML and suppresses replication and the assembly of HSV replication compartments.
    Xu P; Roizman B
    Proc Natl Acad Sci U S A; 2017 May; 114(19):E3823-E3829. PubMed ID: 28439026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells.
    Sourvinos G; Tavalai N; Berndt A; Spandidos DA; Stamminger T
    J Virol; 2007 Sep; 81(18):10123-36. PubMed ID: 17626080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of ND10 components on epigenetic determinants of early KSHV latency establishment.
    Günther T; Schreiner S; Dobner T; Tessmer U; Grundhoff A
    PLoS Pathog; 2014 Jul; 10(7):e1004274. PubMed ID: 25033267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of the Major ND10 Proteins PML, hDaxx and Sp100 to the Regulation of Human Cytomegalovirus Latency and Lytic Replication in the Monocytic Cell Line THP-1.
    Wagenknecht N; Reuter N; Scherer M; Reichel A; Müller R; Stamminger T
    Viruses; 2015 Jun; 7(6):2884-907. PubMed ID: 26057166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections.
    Tavalai N; Papior P; Rechter S; Leis M; Stamminger T
    J Virol; 2006 Aug; 80(16):8006-18. PubMed ID: 16873257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.
    Geng Y; Monajembashi S; Shao A; Cui D; He W; Chen Z; Hemmerich P; Tang J
    J Biol Chem; 2012 Aug; 287(36):30729-42. PubMed ID: 22773875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs.
    Peche LY; Scolz M; Ladelfa MF; Monte M; Schneider C
    Cell Death Differ; 2012 Jun; 19(6):926-36. PubMed ID: 22117195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PML plays both inimical and beneficial roles in HSV-1 replication.
    Xu P; Mallon S; Roizman B
    Proc Natl Acad Sci U S A; 2016 May; 113(21):E3022-8. PubMed ID: 27162364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Death-domain associated protein-6 (DAXX) mediated apoptosis in hantavirus infection is counter-balanced by activation of interferon-stimulated nuclear transcription factors.
    Khaiboullina SF; Morzunov SP; Boichuk SV; Palotás A; St Jeor S; Lombardi VC; Rizvanov AA
    Virology; 2013 Sep; 443(2):338-48. PubMed ID: 23830076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1.
    Sternsdorf T; Jensen K; Will H
    J Cell Biol; 1997 Dec; 139(7):1621-34. PubMed ID: 9412458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not.
    Wiesmeijer K; Molenaar C; Bekeer IM; Tanke HJ; Dirks RW
    J Struct Biol; 2002; 140(1-3):180-8. PubMed ID: 12490166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
    Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
    Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.